The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Pharmaceuticals

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Submitted by Roots_Analysis on 2020-11-03 07:59.

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

Market-Research

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator

Submitted by Roots_Analysis on 2020-11-03 07:58.

Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers” report features an extensive study of the current market landscape, offe

Market-Research

To order this 350+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-11-03 07:57.

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world

Pharmaceuticals

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

To order this 350 ... Read more

Submitted by Roots_Analysis on 2020-11-03 07:56.

The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030

Market-Research

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-11-03 07:54.

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis

Pharmaceuticals

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access

Submitted by Roots_Analysis on 2020-11-03 07:53.

Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers

Market-Research

To order this 350 ... Read more

Submitted by Roots_Analysis on 2020-11-03 06:34.

The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%

Market-Research

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-11-03 06:31.

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1

Market-Research

Submitted by Roots_Analysis on 2020-11-03 06:23.

The “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution o

Market-Research

To order this 540+ page report, please visit this link

Key Inclusions ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:33.

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Market-Research

The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:32.

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Market-Research

Submitted by Roots_Analysis on 2020-11-02 07:32.

The large volume wearable injectors market is projected to grow at an annualized rate of ~35%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:31.

The large volume wearable injectors market is projected to grow at an annualized rate of ~35%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:31.

The large volume wearable injectors market is projected to grow at an annualized rate of ~35%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:31.

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

Market-Research

Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries; in fact, these ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:30.

ADME studies are considered to be critical in establishing the safety and efficacy of drug candidates. Currently, there are a number of contract research organizations (CROs) that claim to have the necessary capabilities to offer in vitro ADME services. O

Pharmaceuticals

To order this detailed 280+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-11-02 07:30.

gaurav.chaudhary@rootsanalysis.com Over 90 firms are actively involved in providing in vitro ADME testing services; of these, over 30 players claim to provide end-to-end services

Market-Research

ADME studies are considered to be critical in establishing the safety and efficacy of drug candidates. Currently, there are a number of contract research organizations (CROs) that claim to have the necessary capabilities to offer in vitro ADME services. Over time, such service providers

Submitted by Roots_Analysis on 2020-11-02 07:29.

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%

Market-Research

Roots Analysis has done a detailed study on ““In Vitro ADME Testing Services Market, 2019-2030” covering key ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:28.

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis

Market-Research

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced ... Read more

Submitted by Roots_Analysis on 2020-11-02 07:27.

Pages